Is Eliquis a Blood Thinner? Uses, Dosing, and Side Effects

Yes, Eliquis (apixaban) is a blood thinner. Even the FDA’s own patient medication guide describes it that way: “ELIQUIS is a blood thinner medicine that reduces blood clotting.” But the term “blood thinner” is technically a simplification. Eliquis doesn’t actually thin your blood. It interferes with a specific step in the clotting process, making your blood less likely to form dangerous clots.

How Eliquis Works

Eliquis belongs to a class of drugs called factor Xa inhibitors. To understand what that means, it helps to know that blood clotting is a chain reaction involving dozens of proteins. One of those proteins, called factor Xa, plays a central role in producing thrombin, the enzyme that ultimately turns liquid blood into a solid clot. Eliquis blocks factor Xa, which slows thrombin production and makes clots less likely to form.

This is different from older blood thinners like warfarin, which work by broadly suppressing multiple clotting factors at once. Eliquis targets one specific step in the chain, which is why it’s considered more selective. It doesn’t directly affect platelets (the cell fragments that clump together in a cut), though by reducing thrombin it indirectly limits platelet activity too.

What Eliquis Is Prescribed For

Eliquis has several FDA-approved uses, all related to preventing or treating blood clots:

  • Atrial fibrillation: Reducing the risk of stroke in people whose irregular heartbeat allows blood to pool and clot in the heart.
  • Deep vein thrombosis (DVT) and pulmonary embolism (PE): Both treating active clots and preventing them from coming back.
  • Post-surgical clot prevention: Reducing clot risk after hip or knee replacement surgery.

How It Compares to Warfarin

Warfarin was the standard blood thinner for decades, but Eliquis has largely replaced it for many patients. The main advantage is a lower bleeding risk. In patients with atrial fibrillation, those taking Eliquis experienced major bleeding at a rate of about 1.5 per 100 person-years, compared to 2.9 for warfarin. That’s roughly half the rate. Stroke prevention was similar between the two drugs.

Eliquis also comes with practical advantages. Warfarin requires regular blood tests to monitor clotting levels, careful dose adjustments, and strict dietary restrictions around vitamin K-rich foods like leafy greens. Eliquis requires none of that. You take a fixed dose twice a day, and there’s no need for routine blood monitoring.

One area where warfarin still has an edge: reversibility. If you’re on warfarin and experience serious bleeding, vitamin K can reverse its effects quickly and cheaply. Eliquis does have a reversal agent, an IV medication called Andexxa, but it’s only used in hospitals for life-threatening or uncontrolled bleeding.

Typical Dosing

For atrial fibrillation, the standard dose is 5 mg twice daily. A lower dose of 2.5 mg twice daily is used for patients who meet at least two of these criteria: age 80 or older, body weight of 132 pounds (60 kg) or less, or reduced kidney function.

For treating an active blood clot (DVT or PE), the dosing is higher at first: 10 mg twice daily for the first 7 days, then 5 mg twice daily after that. If you’re taking it long-term to prevent clots from returning, the dose drops to 2.5 mg twice daily after at least 6 months of treatment.

After hip replacement, the typical course runs 35 days. After knee replacement, it’s 12 days. In both cases the dose is 2.5 mg twice daily, starting 12 to 24 hours after surgery.

Bleeding Risk and Side Effects

Because Eliquis reduces clotting, the primary risk is bleeding. This can show up as nosebleeds, bleeding gums, heavier menstrual periods, bruising more easily, or cuts that take longer to stop. Most of these are minor nuisances rather than emergencies.

Serious bleeding is less common but possible. Signs to watch for include blood in your urine or stool, coughing up blood, vomit that looks like coffee grounds, or sudden severe headache with no clear cause. These warrant immediate medical attention because they can signal internal bleeding.

Interactions With Pain Relievers

One of the most important things to know while taking Eliquis is that common over-the-counter pain relievers can significantly increase your bleeding risk. NSAIDs like ibuprofen (Advil, Motrin), naproxen (Aleve), and diclofenac all reduce your blood’s clotting ability through a separate mechanism. Combining them with Eliquis essentially doubles up on clot prevention in a way that tips the balance toward dangerous bleeding.

Data from the large ARISTOTLE trial found that patients on oral anticoagulants who started taking NSAIDs had about a 61% higher risk of major bleeding and a 70% higher risk of clinically relevant bleeding compared to those who avoided NSAIDs. Interestingly, the increase in bleeding risk appeared more pronounced in warfarin users than in Eliquis users, but the combination is still considered risky regardless of which blood thinner you’re on. Acetaminophen (Tylenol) is generally the safer choice for pain relief.

Stopping Eliquis Safely

One thing that catches people off guard: you should never stop taking Eliquis abruptly without medical guidance. Stopping suddenly can trigger a rebound increase in clotting risk, which is especially dangerous if you have atrial fibrillation. If you need to stop for surgery or a procedure, your doctor will give you a specific timeline. Eliquis clears your system relatively quickly compared to warfarin, which makes scheduling around procedures more straightforward.